abstract |
The invention relates to compounds according to formula I, which are agonists of formyl peptide receptor 2 (FPR2) and / or agonists of formyl peptide receptor 1 (FPR1). The invention also relates to compositions and methods for using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD) and related diseases. |